South San Francisco, CA · Founded 2020 · Privately Held (backing)
Operator of a drug discovery platform intended to accelerate the development of therapies for complex diseases. Soley Therapeutics is based in South San Francisco, CA and was founded in 2020. It was valued at $700 million at its later-stage round in Jul 2025, the last priced event on record. It has raised $290 million across 1 recorded round; the latest was a $20 million early-stage round in Oct 2020.
PMV mark · valuation
$700.0M
Oct 2026
Priced at
its later-stage round
Jul 2025
Total raised
$290.0M
Last round
Early Stage VC
Oct 2020
Cap table — not yet on record
Soley Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Soley Therapeutics with a free account
·Watch Soley Therapeutics: the Monday email on marks, rounds and moves
Where does Soley Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Soley Therapeutics's 1 recorded funding rounds.
